CANNAINVESTOR Magazine August / September 2017 | Page 88

88

Plant-to-Bloodstream

Initial flow of investment capital in the industry has been “seed-to-plant” companies.

Next flow of investment capital is expected to be “plant-to-bloodstream” companies.

Lexaria disrupts the way cannabinoids enter the bloodstream through the Gastrointestinal Tract